Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Dyne Therapeutics Inc (DYN)

224 + Investors. Track Smart Money conviction in DYN. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -4
Streak
1Q ▼
Buyers last Q
57%

Smart Money Signals — DYN

Based on 225 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds reduced or closed their DYN positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
🏔️

At the ownership peak (98% of max)

98% of all-time peak
225 hedge funds hold DYN right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
📶

Steady growth — +12% more funds vs a year ago

fund count last 6Q
+25 new funds entered over the past year (+12% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟡

Slight buying edge — 57% buying

144 buying107 selling
Last quarter: 144 funds bought or added vs 107 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
⚠️

Fewer new buyers each quarter (-16 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 22 → 39 → 58 → 42. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
🔒

43% of holders stayed for 2+ years

■ 43% conviction (2yr+) ■ 29% medium ■ 28% new
96 out of 225 hedge funds have held DYN for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares +13%, value -13%

Value
-13%
Shares
+12%
Last quarter: funds added +13% more shares while total portfolio value only changed -13%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
🚀

Acceleration phase — new buyers rushing in

47 → 22 → 39 → 58 → 42 new funds/Q
New funds entering each quarter: 22 → 39 → 58 → 42. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
🏛️

Veteran-anchored — 45% veterans vs 32% newcomers

■ 45% veterans ■ 23% 1-2yr ■ 32% new
Entry-cohort mix of 231 holders: 105 (45%) are 2+ year veterans, 53 entered 1–2 years ago, and 73 (32%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
✅

Strong quality — 31% AUM from major funds

31% from top-100 AUM funds
43 of 224 holders rank in the top 100 by AUM, accounting for 31% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
3.9
out of 10
Low Exit Risk
Exit risk score 3.9/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — DYN

In 2026 Q1, 144 hedge funds were net buyers of DYN (42 opened a new position, 102 added to an existing one), while 107 reduced or exited (61 trimmed, 46 sold completely) — a 57% buyer ratio, indicating a slight buying edge. 31% of total institutional value in DYN is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: -4 funds (more exits than new entries). Total institutional holders: 225.

Hedge Fund Ownership: DYN

How many hedge funds hold DYN — quarterly history vs. share price
Quarterly hedge fund ownership of DYN vs. share price

Market Analysis: DYN

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: DYN

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Dyne Therapeutics Inc (DYN) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much DYN has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 83d ago
DYN
+14.5%
XLV
+710.3%

DYN outperformed XLV by -695.8% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 38d ago
DYN
+20.0%
XLV
+697.2%

Since the filing became public, DYN outperformed XLV by -677.2% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

23 top-rated funds 5 high-conviction
Consensus
6.0
/ 10
breadth
×
Elite
4.6
/ 10
conviction
Hedge Fund Positioning: DYN
224 + Investors

Track Smart Money conviction in DYN. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 224 229 -2.18%
13F Shares 185M 164M 12.84%
Total Value $2.74B $3.16B -13.23%
New Positions 41 58 -17
Increased Positions 98 94 +4
Closed Positions 46 32 +14
Reduced Positions 61 58 +3
Total Calls 3 4 -25.0%
Total Puts 4 5 -20.0%
PUT/CALL Ratio 1.33 1.25 Bearish

Statistics: DYN

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

224 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in DYN. Verified SEC 13F-HR filings.

QUARTER:
Top 25 DYN holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Atlas Venture Life Science Advisors, LLC 20.95% 9,130,465 $165.5M
2 Fcpm III Services B.V. 11.66% 4,644,386 $84.2M
3 University of Wisconsin Foundation 7.80% 484,745 $8.8M
4 Palo Alto Investors LP 4.58% 1,652,972 $30.0M
5 Saturn V Capital Management LP 3.17% 966,609 $17.5M
6 TCG Crossover Management, LLC 2.39% 4,615,144 $83.7M
7 Vivo Capital, LLC 2.36% 1,557,466 $28.2M
8 Vestal Point Capital, LP 2.03% 4,000,000 $72.5M
9 MPM BioImpact LLC 1.97% 1,408,152 $25.5M
10 Lion Point Capital, LP 1.95% 18,000 $326K
11 Stempoint Capital LP 1.78% 506,075 $9.2M
12 Perceptive Advisors LLC 1.66% 4,668,839 $84.6M
13 Venrock Adviser, LLC 1.47% 2,173,913 $39.4M
14 Frazier Life Sciences Management, L.P. 1.47% 3,153,082 $57.2M
15 Aegis Wealth Management LLC 1.40% 135,030 $2.4M
16 Logos Global Management LP 1.27% 1,400,000 $25.4M
17 Sofinnova Investments, Inc. 1.13% 1,633,897 $29.6M
18 Siren, L.L.C. 1.12% 2,229,125 $40.4M
19 Catalio Capital Management, LP 1.07% 282,954 $5.1M
20 Orbimed Advisors LLC 1.05% 2,917,884 $52.9M
21 Rock Springs Capital Management LP 1.04% 972,198 $17.6M
22 Armistice Capital, LLC 1.02% 3,175,110 $57.6M
23 Braidwell LP 1.02% 1,681,998 $30.5M
24 HighVista Strategies LLC 0.92% 182,929 $3.3M
25 Tetragon Partners GP Ltd 0.91% 258,132 $4.7M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Dyne Therapeutics Inc (DYN)

What does the Smart Money Trend signal show for DYN?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their DYN positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for DYN?

Slight buying edge — 57% buying: Last quarter: 144 funds bought or added vs 107 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for DYN holders?

Strong quality — 31% AUM from major funds: 43 of 224 holders rank in the top 100 by AUM, accounting for 31% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held DYN?

43% of holders stayed for 2+ years: 96 out of 225 hedge funds have held DYN for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Dyne Therapeutics Inc (DYN) following the 2026 Q1 hedge fund 13F filings?

As of today, DYN has moved +20.0% since the 2026 Q1 13F filing date (May 15, 2026), compared to +697.2% for the XLV sector ETF — an outperformance of -677.2%. Since the quarter end (March 31, 2026), DYN has gained +14.5% vs +710.3% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →